Marc Kerenyi

Bis 2014, Postdoctoral Research Fellow, Boston Children's Hospital - Harvard Medical School

Boston, Vereinigte Staaten

Fähigkeiten und Kenntnisse

Hematology
Epigenetics
Oncology
Immunology
Animal Model / Disease Model
Next Generation Sequencing (NGS)
Chromatin immunoprecipitation
Primary Tissue Culture
Scientific and Grant Application writing
Flow Cytometry
Global Gene Expression Profiling
Supervision and Development of Students and Resear
Genome Engineering (Cas9/Crispr)
Stem Cell Biology (adult hematopoietic and embryon
Strong Communication Skills
Excellent Problem Solver
Cooperation
Bioinformatics

Werdegang

Berufserfahrung von Marc Kerenyi

  • Bis heute 8 Jahre und 9 Monate, seit Sep. 2015

    Research Laboratory Head

    Boehringer Ingelheim
  • 5 Jahre und 6 Monate, Jan. 2009 - Juni 2014

    Postdoctoral Research Fellow

    Boston Children's Hospital - Harvard Medical School

    Explored epigenetic mechanisms of histone demethylases (LSD1, UTX & JMJD3) in hematopoietic development and lymphoid & myeloid leukemias by generating mouse models; applied multi-color flow cytometry, global gene expression profiling and ChIP-sequencing; wrote grant proposals and scientific papers; reviewed scientific publications; hired and supervised Research Assistants; participated and presented at weekly lab meetings, department meetings and international conferences.

  • 4 Jahre, Jan. 2005 - Dez. 2008

    Graduate Student

    Research Institute of Molecular Pathology

    Analyzed how STAT5 regulates hematopoietic development, iron metabolism and disease progression using animal models and primary tissue culture systems; wrote scientific papers; supervised and mentored undergraduate student; organized bi-weekly journal club; participated and presented at weekly lab meetings, department meetings and international conferences.

  • 1 Jahr und 1 Monat, Nov. 2003 - Nov. 2004

    Undergraduate Student

    Research Institute of Molecular Pathology

    Studied transcriptional regulation by the transcription factor STAT5 during erythroid differentiation using primary tissue culture systems; participated and presented at weekly lab meetings and international conferences.

Ausbildung von Marc Kerenyi

  • 3 Jahre und 10 Monate, Jan. 2005 - Okt. 2008

    Molecular Biology

    Universität Wien

    Transcription Factors, Myeloid Leukemia, Immunology, Erythropoiesis, Anemia, Iron Metabolism

  • 5 Jahre und 4 Monate, Okt. 1999 - Jan. 2005

    Molecular Biology

    Universität Wien

    Biochemistry, Tissue Culture, Molecular Biology

Sprachen

  • Englisch

    Fließend

  • Deutsch

    Muttersprache

  • Französisch

    Grundlagen

21 Mio. XING Mitglieder, von A bis Z